Glycoengineering in cancer therapeutics: a review with fucose-depleted trastuzumab as the model.
Anticancer Drugs. 2013 Mar;24(3):219-27. doi: 10.1097/CAD.0b013e328359e3f4.
Anticancer Drugs. 2013.
PMID: 23059384
Review.